Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Lestaurtinib

EU orphan designation number: EU/3/06/389
Active ingredient: Lestaurtinib
Indication: Treatment of acute myeloid leukaemia
Sponsor: Teva Santé
100-11 esplanade du Général de Gaulle, 92931 La Défense Cedex, Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2006 Orphan designation EMEA/OD/020/06 (2006)3438 of 25/07/2006
25/05/2007 Transfer of orphan designation EMEA/OD/020/06/T/01 (2007)2285 of 22/05/2007
25/02/2014 Change of name and/or address of sponsor
01/04/2015 Removal of orphan designation from Community Register